Lindbrook Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Lindbrook Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,246	Closed	-$1.36M	–	2944
2024 Q4	$1.37M	Sell	15,246 -7,360	-33%	-$713K	0.12%	102
2024 Q3	$2.23M	Sell	22,606 -16,568	-42%	-$1.63M	0.2%	73
2024 Q2	$3.63M	Sell	39,174 -14,354	-27%	-$1.29M	0.34%	51
2024 Q1	$5.08M	Buy	53,528 +5,573	+12%	+$517K	0.48%	40
2023 Q4	$4.28M	Buy	47,955 +308	+0.6%	+$22.9K	0.43%	44
2023 Q3	$3.48M	Buy	47,647 +560	+1%	+$44.7K	0.39%	46
2023 Q2	$3.92M	Buy	47,087 +1,244	+3%	+$104K	0.42%	43
2023 Q1	$3.49M	Buy	45,843 +675	+1%	+$56K	0.41%	47
2022 Q4	$3.75M	Buy	+45,168	New	+$3.66M	0.46%	46
2022 Q1	–	Sell	-38	Closed	-$4K	–	2631
2021 Q4	$4K	Buy	+38	New	+$4.58K	﹤0.01%	1617
2021 Q2	–	Sell	-158	Closed	-$21K	–	2011
2021 Q1	$21K	Hold	158	–	–	﹤0.01%	747
2020 Q4	$22K	Hold	158	–	–	0.01%	656
2020 Q3	$18K	Hold	158	–	–	0.01%	654
2020 Q2	$18K	Hold	158	–	–	0.01%	652
2020 Q1	$12K	Hold	158	–	–	﹤0.01%	709
2019 Q4	$15K	Hold	158	–	–	0.01%	819
2019 Q3	$12K	Buy	158 +1	+0.6%	+$83	﹤0.01%	856
2019 Q2	$13K	Hold	157	–	–	0.01%	826
2019 Q1	$14K	Hold	157	–	–	0.01%	808
2018 Q4	$11K	Buy	+157	New	+$12.7K	0.01%	811

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Lindbrook Capital's XBI Position: Q1 2025 in Review

Lindbrook Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 15,246 shares — an estimated $1.36M sold.

Lindbrook Capital first reported a position in XBI in Q4 2018 and held it in 20 quarters. The position peaked at $5.08M in Q1 2024. 683 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Lindbrook Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Lindbrook Capital sold 15,246 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $1.36M.
Lindbrook Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 20 quarters.
Lindbrook Capital's State Street SPDR S&P Biotech ETF position peaked at $5.08M in Q1 2024.
683 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.